Human Challenge Studies to Accelerate Coronavirus Vaccine Licensure
Oxford University Press -- The Journal of Infectious Diseases
DOI 10.1093/infdis/jiaa152
  1. coronavirus
  2. vaccines
  3. human challenge studies
  4. randomized controlled trials
  5. risk-taking
  6. ethics

Controlled human challenge trials of SARS-CoV-2 vaccine candidates could accelerate the testing and potential rollout of efficacious vaccines, reducing the global burden of coronavirus-related mortality and morbidity. Volunteers’ net risk in such studies could be acceptable under specific conditions.